Regulatory T cells in human autoimmune thyroid disease.

CONTEXT T regulatory cells have a key role in the pathogenesis of autoimmune diseases in different animal models. However, less information is available regarding these cells in human autoimmune thyroid diseases (AITD). OBJECTIVE The objective of the study was to analyze different regulatory T cell subsets in patients with AITD. DESIGN We studied by flow cytometry and immunohistochemistry different T regulatory cell subsets in peripheral blood mononuclear cells (PBMCs) and thyroid cell infiltrates from 20 patients with AITD. In addition, the function of T(REG) lymphocytes was assessed by cell proliferation assays. Finally, TGF-beta mRNA in thyroid tissue and its in vitro synthesis by thyroid mononuclear cells (TMCs) was determined by RNase protection assay and quantitative PCR. RESULTS PBMCs from AITD patients showed an increased percent of CD4+ lymphocytes expressing glucocorticoid-induced TNF receptor (GITR), Foxp3, IL-10, TGF-beta, and CD69 as well as CD69+CD25(bright), CD69+TGF-beta, and CD69+IL-10+ cells, compared with controls. TMCs from these patients showed an increased proportion of CD4+GITR+, CD4+CD69+, and CD69+ cells expressing CD25(bright), GITR, and Foxp3, compared with autologous PBMCs. Furthermore, a prominent infiltration of thyroid tissue by CD69+, CD25+, and GITR+ cells, with moderate levels of Foxp3+ lymphocytes, was observed. The suppressive function of peripheral blood T(REG) cells was defective in AITD patients. Finally, increased levels of TGF-beta mRNA were found in thyroid tissue, and thyroid cell infiltrates synthesized in vitro significant levels of TGF-beta upon stimulation through CD69. CONCLUSIONS Although T regulatory cells are abundant in inflamed thyroid tissue, they are apparently unable, in most cases, to downmodulate the autoimmune response and the tissue damage seen in AITD.

[1]  R. Flavell,et al.  Cutting Edge: Deficiency in the E3 Ubiquitin Ligase Cbl-b Results in a Multifunctional Defect in T Cell TGF-β Sensitivity In Vitro and In Vivo , 2006, The Journal of Immunology.

[2]  R. Sinden,et al.  Upregulation of TGF-beta, FOXP3, and CD4+CD25+ regulatory T cells correlates with more rapid parasite growth in human malaria infection. , 2005, Immunity.

[3]  A. Thornton.  T regulatory cells , 2005, Current Biology.

[4]  R. González-Amaro,et al.  Immune effects of therapy with Adalimumab in patients with rheumatoid arthritis , 2005, Clinical and experimental immunology.

[5]  B. Prabhakar,et al.  IL-10-Producing CD4+CD25+ Regulatory T Cells Play a Critical Role in Granulocyte-Macrophage Colony-Stimulating Factor-Induced Suppression of Experimental Autoimmune Thyroiditis1 , 2005, The Journal of Immunology.

[6]  R. Lechler,et al.  MRL/Mp CD4+,CD25- T cells show reduced sensitivity to suppression by CD4+,CD25+ regulatory T cells in vitro: a novel defect of T cell regulation in systemic lupus erythematosus. , 2005, Arthritis and rheumatism.

[7]  S. Sakaguchi.  Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self , 2005, Nature Immunology.

[8]  A. Rudensky,et al.  A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3 , 2005, Nature Immunology.

[9]  F. Sánchez‐Madrid,et al.  CD69 is an immunoregulatory molecule induced following activation. , 2005, Trends in immunology.

[10]  L. Maiuri,et al.  High incidence of spontaneous autoimmune thyroiditis in immunocompetent self-reactive human T cell receptor transgenic mice. , 2005, Journal of autoimmunity.

[11]  J. Bijlsma,et al.  CD4(+)CD25(+) regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. , 2004, Arthritis and rheumatism.

[12]  E. Shevach.  Regulatory/suppressor T cells in health and disease. , 2004, Arthritis and rheumatism.

[13]  D. Isenberg,et al.  Compromised Function of Regulatory T Cells in Rheumatoid Arthritis and Reversal by Anti-TNFα Therapy , 2004, The Journal of experimental medicine.

[14]  L. Chatenoud,et al.  Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[15]  H. Waldmann,et al.  Mouse glucocorticoid-induced tumor necrosis factor receptor ligand is costimulatory for T cells , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[16]  E. Esplugues,et al.  CD69 downregulates autoimmune reactivity through active transforming growth factor-beta production in collagen-induced arthritis. , 2003, The Journal of clinical investigation.

[17]  H. Ochs,et al.  Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis , 2003, Current opinion in rheumatology.

[18]  B. Prabhakar,et al.  Selective Induction of Dendritic Cells Using Granulocyte Macrophage-Colony Stimulating Factor, But Not fms-Like Tyrosine Kinase Receptor 3-Ligand, Activates Thyroglobulin-Specific CD4+/CD25+ T Cells and Suppresses Experimental Autoimmune Thyroiditis1 , 2003, The Journal of Immunology.

[19]  B. Prabhakar,et al.  Targeted engagement of CTLA-4 prevents autoimmune thyroiditis. , 2003, International immunology.

[20]  C. Baecher-Allan,et al.  Isolation and functional characterization of regulatory CD25brightCD4+ T cells from the target organ of patients with rheumatoid arthritis , 2003, European journal of immunology.

[21]  Å. Lernmark,et al.  Animal models of endocrine/organ-specific autoimmune diseases: do they really help us to understand human autoimmunity? , 2002, Springer Seminars in Immunopathology.

[22]  C. Goulvestre,et al.  Chemokines modulate experimental autoimmune thyroiditis through attraction of autoreactive or regulatory T cells , 2002, European journal of immunology.

[23]  A. Miyauchi,et al.  Independent involvement of CD8+ CD25+ cells and thyroid autoantibodies in disease severity of Hashimoto's disease. , 2002, Thyroid : official journal of the American Thyroid Association.

[24]  G. Stassi,et al.  Autoimmune thyroid disease: new models of cell death in autoimmunity , 2002, Nature Reviews Immunology.

[25]  F. Sánchez‐Madrid,et al.  Thyrocytes from autoimmune thyroid disorders produce the chemokines IP-10 and Mig and attract CXCR3+ lymphocytes. , 2001, The Journal of clinical endocrinology and metabolism.

[26]  M. Roncarolo,et al.  Type 1 T regulatory cells , 2001, Immunological reviews.

[27]  F. Batteux,et al.  Curative treatment of experimental autoimmune thyroiditis by in vivoadministration of plasmid DNA coding for interleukin‐10 , 1999, European journal of immunology.

[28]  G. Sharp,et al.  Interleukin-12 promotes activation of effector cells that induce a severe destructive granulomatous form of murine experimental autoimmune thyroiditis. , 1998, The American journal of pathology.

[29]  Y. Kohno,et al.  Induction of Graves-like disease in mice by immunization with fibroblasts transfected with the thyrotropin receptor and a class II molecule. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[30]  S. Sakaguchi,et al.  Autoimmune disease as a consequence of developmental abnormality of a T cell subpopulation , 1996, The Journal of experimental medicine.

[31]  M. Fisfalen,et al.  Immunosuppression of thyroiditis. , 1996, Endocrinology.

[32]  W. Scherbaum,et al.  Different cytokine mRNA profiles in Graves' disease, Hashimoto's thyroiditis, and nonautoimmune thyroid disorders determined by quantitative reverse transcriptase polymerase chain reaction (RT-PCR). , 1996, Thyroid : official journal of the American Thyroid Association.

[33]  A. Weetman,et al.  Autoimmune thyroid disease: further developments in our understanding. , 1994, Endocrine reviews.

[34]  F. Sánchez‐Madrid,et al.  Adhesion molecules from the LFA‐1/ICAM‐1, 3 and VLA‐4/VCAM‐1 pathways on T lymphocytes and vascular endothelium in Graves' and Hashimoto's thyroid glands , 1994, European journal of immunology.

[35]  R. Scorza,et al.  Regulatory CD8+ T cells control thyrotropin receptor-specific CD4+ clones in healthy subjects. , 2003, Cancer detection and prevention.

[36]  D. Galas,et al.  Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse , 2001, Nature Genetics.

[37]  F. Sánchez‐Madrid,et al.  Cell adhesion molecules: selectins and integrins. , 1999, Critical reviews in immunology.

[38]  R Volpé,et al.  Autoimmune thyroid disease. , 1984, Hospital practice.